ESR1 and breast cancer: Hsieh et al. (2015) showed that the expression of a newly discovered tumor suppressor, microRNA 125a-5p (miR-125a-5p), was induced by silencing of HDAC5 in the ER+/HER2+ R2N1d breast cancer cells in a dose-dependent manner.